Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03913286 · ClinicalTrials.gov registry record · NA
Neuromotor Prosthetic to Treat Stroke-Related Paresis
A NA study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03913286: Completed NA study, sponsored by Thomas Jefferson University.
NCT03913286 is a NA study that has completed, run by Thomas Jefferson University. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03913286, a NA study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of the research is to develop a new medical device prototype to restore functional movement of an arm made weak due to a chronic stroke
Primary Outcome
The Fugl-Meyer assessment (FMA) is a stroke specific index for estimating the performance of motor function. Total scores of FMA-Upper limb range from 0-66. From: Fugl-Meyer et al. The post-stroke hemiplegic patient: a method for evaluation of physical performance. Scand. J. Rehabil. Med., 1975.
Interventions
- DEVICE Cortimo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2024-07-01 |
| Phase | NA |
What the finished NCT03913286 record still lists
NCT03913286 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Cortimo is the first listed.
NCT03913286 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03913286 about?
NCT03913286 is a clinical study titled "Neuromotor Prosthetic to Treat Stroke-Related Paresis". The purpose of the research is to develop a new medical device prototype to restore functional movement of an arm made weak due to a chronic stroke
What is the current status of trial NCT03913286?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2019-05-01. Estimated completion is 2024-07-01.
What interventions are being tested in trial NCT03913286?
The interventions under investigation include: Cortimo (DEVICE).
Who is sponsoring clinical trial NCT03913286?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03913286's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI